Top Gainers at a Glance -- Research on Ameriprise Financial, Endeavour Silver, Celldex Therapeutics, and Buffalo Wild Wings - Wandtv.com, NewsCenter17, StormCenter17, Central Illinois News-

Top Gainers at a Glance -- Research on Ameriprise Financial, Endeavour Silver, Celldex Therapeutics, and Buffalo Wild Wings

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Investor-Edge

Editor Note: For more information about this release, please scroll to bottom.

LONDON, May 1, 2014 /PRNewswire/ --

The US markets saw a positive sentiment on Tuesday, April 29, 2014, with the NASDAQ Composite closing at 4,103.54, up 0.72%, the Dow Jones Industrial Average ending the session at 16,535.37, up 0.53% and the S&P 500 finishing 0.48% higher at 1,878.33. The gains were broad based as eight out of ten sectors finished on a positive note. A number of stocks saw large movements, including Ameriprise Financial Inc. (NYSE: AMP), Endeavour Silver Corp. (NYSE: EXK), Celldex Therapeutics Inc. (NASDAQ: CLDX) and Buffalo Wild Wings Inc. (NASDAQ: BWLD). Free technical research on AMP, EXK, CLDX and BWLD can be downloaded upon signing up at:

http://www.investor-edge.com/1914-register

On Tuesday, shares of Ameriprise Financial Inc. fluctuated between $106.98 and $109.91 before ending the session 5.84% higher at $109.55. Shares of Ameriprise Financial Inc. reported a trading volume of 1.99 million shares, above its three months average volume of 1.24 million shares. Ameriprise Financial Inc.'s shares have gained 3.50% in the previous three trading sessions and 0.68% in the last one month. However, the stock has declined 4.78% on YTD basis. The S&P 500 Financials Sector Index mapped a gain of 0.95% during the trading session, and the same has charted up 4.30% in the last three months. The stock is trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $108.25 is above its 200-day moving average of $101.52. Ameriprise Financial Inc.'s stock traded at a PE ratio of 15.36 and has a Relative Strength Index (RSI) of 39.75. On Monday, April 28, 2014, the company announced its Q1 FY2014 results. The company reported Q1 FY2014 operating earnings of $407 million, up 20% from a year ago quarter. In addition, the company's operating earnings per diluted share rose to $2.04, representing a hike of 28% from the prior year quarter. Sign up today to read free research on AMP at:

http://www.investor-edge.com/1914-AMP-30Apr2014.pdf

Endeavour Silver Corp.'s stock surged 7.26% on Tuesday, closing the day at $4.73. The stock recorded a trading volume of 1.58 million shares, above its three months average volume of 1.51 million shares. The stock oscillated between $4.36 and $4.73 during the trading session. Over the previous three trading sessions and in the last one month, Endeavour Silver Corp.'s stock has gained 7.01% and 4.42%, respectively. Moreover, the stock has surged 30.30% since the start of this year. The S&P 500 Materials Sector Index mapped a gain of 0.74% during the trading session and 0.96% in the last one month. The stock is trading below its 50-day moving average. The stock's 50-day moving average of $4.85 is above its 200-day moving average of $4.34. Further, shares of the company have an RSI of 47.68. Sign up today to read free research on EXK at:

http://www.investor-edge.com/1914-EXK-30Apr2014.pdf

Shares of Celldex Therapeutics Inc. finished Tuesday's session 6.87% higher at $14.78. A total of 2.02 million shares were traded, compared its three months average volume of 2.48 million shares. The stock moved between $13.57 and $14.88 during the session. Over the last one month and from the start of this year, Celldex Therapeutics Inc.'s stock has declined 12.80% and 38.95%, respectively. However, the stock has advanced 0.68% in the previous three trading sessions. The S&P 500 Health Care Sector Index mapped a gain of 0.62% during the trading session, and the index has charted up 0.48% in the previous three trading sessions. The company's shares are trading below its 50-day and 200-day moving averages of $21.42 and $24.00, respectively. Furthermore, Celldex Therapeutics Inc.'s stock has an RSI of 34.23. Sign up today to read free research on CLDX at:

http://www.investor-edge.com/1914-CLDX-30Apr2014.pdf

On Tuesday, Buffalo Wild Wings Inc.'s stock recorded a trading volume of 2.06 million shares, much above to its three months average volume of 0.58 million shares. The stock ended the day at $140.14, which was 5.06% higher than its previous day's closing, and registered an intraday range of $136.76 and $143.90. However, Buffalo Wild Wings Inc.'s shares have lost 5.00% in the last one month and 4.80% on YTD basis. However, the stock has gained 5.34% in the previous three months. The S&P 500 Consumer Discretionary Sector Index gained 0.40% during the trading session, and the index has charted up 1.45% in the previous three months. The company's stock is trading below its 50-day moving average. Buffalo Wild Wings Inc.'s 50-day moving average of $143.63 is above its 200-day moving average of $130.26. Moreover, shares of the company traded at a PE ratio of 31.13 and have an RSI of 36.55. Buffalo Wild Wings Inc. announced its Q1 FY2014 (period ended March 30, 2014) results on Monday, April 28, 2014. The company reported that its Q1 FY2014 total revenue increased 20.9% to $367.9 million compared with $304.4 million in the first quarter of 2013. Sign up today to read free research on BWLD at:

http://www.investor-edge.com/1914-BWLD-30Apr2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


Investor-Edge.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

904 South Side Drive
Decatur, IL 62521
Primary Phone: 217-424-2500
Primary Email: news@wandtv.com

All content © Copyright 2000 - 2014, WorldNow and WAND. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms